Oral Infections: Dietary Regulation of Local and Systemic Inflammatory Responses

Sponsor
University of Kentucky (Other)
Overall Status
Completed
CT.gov ID
NCT00632957
Collaborator
National Institutes of Health (NIH) (NIH), National Center for Research Resources (NCRR) (NIH)
126
1
2
56
2.3

Study Details

Study Description

Brief Summary

The purpose of this study is to test the hypothesis that dietary n-3 PUFA will have a beneficial effect on systemic and local markers of inflammation when combined with traditional, non-surgical periodontal therapy.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Omega-3 Fatty acid (with SRP or OHI)
  • Dietary Supplement: Placebo
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
126 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Center for the Biologic Basis of Oral/Systemic Diseases Project 5: Oral Infections: Dietary Regulation of Local and Systemic Inflammatory Responses.
Study Start Date :
Sep 1, 2004
Actual Primary Completion Date :
May 1, 2009
Actual Study Completion Date :
May 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Fish oil

Dietary Supplement: Omega-3 Fatty acid (with SRP or OHI)
1000mg capsules three times daily, duration 28 weeks.

Placebo Comparator: Placebo

Dietary Supplement: Placebo
corn/soybean oil capsules 1g/three times daily

Outcome Measures

Primary Outcome Measures

  1. clinical attachment loss [baseline, 8, 16, 28 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. ≥ 18 years of age, male or female

  2. At least 20 natural teeth present at the time of periodontal examination

  3. Be diagnosed with severe, chronic periodontitis;

  4. Be willing to participate in the study

Exclusion Criteria:
  1. <18 years of age

  2. Less than 20 natural teeth present at time of periodontal examination

  3. Unable or unwilling to provide informed consent or follow study protocol

  4. Systemic conditions including diabetes mellitus and any cardiovascular condition that would require premedication prior to dental treatment

  5. Use of systemic antibiotics within the last 3 months

  6. Pregnancy as diagnosed by administered pregnancy test.

  7. You are nursing a baby.

  8. Are allergic to fish or fish products.

  9. You are taking any other medications, such as dietary supplements, that could affect the outcome of the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Kentucky College of Dentistry Lexington Kentucky United States 40536

Sponsors and Collaborators

  • University of Kentucky
  • National Institutes of Health (NIH)
  • National Center for Research Resources (NCRR)

Investigators

  • Principal Investigator: Dolph R. Dawson, DMD,MS, University of Kentucky College of Dentistry
  • Study Chair: Jeff L. Ebersole, Ph.D, University of Kentucky College of Dentistry
  • Study Director: M J Novak, Ph.D, University of Kentucky College of Dentistry
  • Study Director: Gilbert A. Boissonneault, Ph.D, University of Kentucky Division of Clinical Nutrition

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00632957
Other Study ID Numbers:
  • UK IRB # 04-0339-F1V
  • P20RR020145-04
First Posted:
Mar 11, 2008
Last Update Posted:
Apr 12, 2011
Last Verified:
Apr 1, 2011
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 12, 2011